HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavel Hamet Selected Research

Gliclazide (Diamicron)

1/2021The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.
1/2021Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial.
12/2020Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
1/2020The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
1/2020Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.
11/2019The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
1/2019Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.
1/2019Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
1/2019Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
1/2018Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavel Hamet Research Topics

Disease

38Hypertension (High Blood Pressure)
01/2019 - 01/2002
36Vascular Diseases (Vascular Disease)
03/2021 - 11/2002
34Type 2 Diabetes Mellitus (MODY)
01/2021 - 02/2008
12Albuminuria
01/2019 - 06/2005
10Cardiovascular Diseases (Cardiovascular Disease)
11/2019 - 06/2005
9Diabetes Mellitus
01/2019 - 06/2002
9Heart Failure
01/2018 - 06/2004
8Stroke (Strokes)
01/2021 - 06/2002
8Myocardial Infarction
01/2019 - 06/2005
8Hyperplasia
01/2016 - 03/2003
8Body Weight (Weight, Body)
05/2010 - 12/2004
7Obesity
12/2020 - 06/2002
7Isolated Systolic Hypertension
01/2017 - 06/2005
7Cushing Syndrome
08/2014 - 10/2004
7Chronic Renal Insufficiency
05/2012 - 06/2005
5Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2016 - 03/2004
5Dyslipidemias (Dyslipidemia)
05/2010 - 03/2004
4Diabetes Complications
10/2021 - 01/2016
4Neoplasms (Cancer)
06/2021 - 10/2004
4Kidney Diseases (Kidney Disease)
11/2019 - 07/2011
4Insulin Resistance
11/2019 - 11/2002
4Coronary Artery Disease (Coronary Atherosclerosis)
05/2014 - 08/2007
4Adenoma (Adenomas)
07/2010 - 08/2005
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2010 - 05/2007
3Chronic Kidney Failure (Chronic Renal Failure)
05/2016 - 03/2013
3Ischemia
01/2014 - 11/2002
3Acth-Independent Macronodular Adrenal Hyperplasia
07/2010 - 01/2006
3Pituitary ACTH Hypersecretion
09/2006 - 08/2005
3Hypertrophy
01/2005 - 04/2003
2Renal Insufficiency (Renal Failure)
01/2022 - 01/2016
2Genetic Risk Score
10/2021 - 01/2021
2Diabetic Nephropathies (Diabetic Nephropathy)
03/2021 - 03/2016
2Frailty
01/2021 - 01/2017
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2016 - 05/2014
2Blindness (Hysterical Blindness)
01/2016 - 01/2016
2Hyperaldosteronism (Conn Syndrome)
01/2016 - 07/2010
2Atherosclerosis
12/2014 - 01/2014
2Inflammation (Inflammations)
03/2014 - 11/2002
2Atrial Fibrillation
05/2012 - 06/2011
2Reperfusion Injury
11/2011 - 11/2002
2Carcinoma (Carcinomatosis)
07/2010 - 11/2009
2Essential Hypertension
03/2010 - 01/2002
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2004 - 03/2003
2Necrosis
06/2004 - 11/2002

Drug/Important Bio-Agent (IBA)

34Gliclazide (Diamicron)IBA
01/2021 - 06/2008
33perindopril drug combination indapamideIBA
03/2021 - 04/2009
20Glucose (Dextrose)FDA LinkGeneric
10/2021 - 10/2003
9Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 06/2005
9PerindoprilFDA LinkGeneric
01/2019 - 04/2009
9Angiotensin Receptor AntagonistsIBA
01/2018 - 01/2002
8AlbuminsIBA
03/2021 - 06/2011
8CholesterolIBA
01/2021 - 06/2005
8IndapamideFDA LinkGeneric
01/2019 - 04/2009
8SaltsIBA
03/2015 - 06/2005
7CreatinineIBA
01/2021 - 06/2011
7Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2016 - 06/2005
7LipidsIBA
01/2016 - 06/2002
71,4-dihydropyridine (dihydropyridine)IBA
07/2011 - 06/2005
6Ouabain (G Strophanthin)IBA
01/2014 - 01/2002
6Proteins (Proteins, Gene)FDA Link
06/2012 - 10/2003
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2011 - 06/2005
6ThiazidesIBA
05/2010 - 06/2005
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2010 - 06/2005
5Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2014
5Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 06/2002
5CalciumIBA
09/2017 - 06/2005
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2016 - 10/2004
4Insulin (Novolin)FDA Link
11/2019 - 06/2002
4Uric Acid (Urate)IBA
10/2019 - 12/2016
4Adenosine Triphosphatases (ATPase)IBA
03/2015 - 06/2004
4Dietary SodiumIBA
05/2010 - 05/2007
4DiureticsIBA
05/2010 - 05/2007
4Adrenocorticotropic Hormone (ACTH)FDA Link
09/2006 - 10/2004
3SodiumIBA
01/2019 - 11/2002
3C-Reactive ProteinIBA
01/2017 - 08/2007
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2014 - 06/2008
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2014 - 06/2005
3Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
07/2011 - 05/2007
3AldosteroneIBA
07/2010 - 04/2005
3Hormones (Hormone)IBA
07/2010 - 10/2004
3gastric inhibitory polypeptide receptorIBA
09/2006 - 08/2005
3LeptinIBA
12/2004 - 11/2002
2ErbB Receptors (EGF Receptor)IBA
06/2021 - 09/2017
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 03/2014
2Small Interfering RNA (siRNA)IBA
01/2014 - 10/2010
2Triglycerides (Triacylglycerol)IBA
01/2014 - 05/2007
2LithiumIBA
06/2011 - 11/2002
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2010 - 10/2004
2Pharmaceutical PreparationsIBA
06/2007 - 01/2005
2Nonesterified Fatty Acids (NEFA)IBA
05/2007 - 12/2004
2Cardiac GlycosidesIBA
12/2006 - 06/2004
2Atrial Natriuretic Factor (ANF)IBA
12/2005 - 01/2003
2CaspasesIBA
06/2004 - 04/2003
2benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
06/2004 - 04/2003
2Messenger RNA (mRNA)IBA
01/2003 - 11/2002

Therapy/Procedure

21Therapeutics
01/2021 - 06/2002
3Glycemic Control
08/2014 - 06/2008
2Kidney Transplantation
05/2016 - 03/2013
2Surgical Amputation (Amputations)
01/2016 - 01/2016
2Adrenalectomy
01/2016 - 07/2010